{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T05:07:31Z","timestamp":1789967251194,"version":"4.0.1"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1186\/s12885-016-2991-9","type":"journal-article","created":{"date-parts":[[2017,1,5]],"date-time":"2017-01-05T14:44:24Z","timestamp":1483627464000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Establishing a xenograft mouse model of peritoneal dissemination of gastric cancer with organ invasion and fibrosis"],"prefix":"10.1186","volume":"17","author":[{"given":"Mitsuyoshi","family":"Okazaki","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sachio","family":"Fushida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinichi","family":"Harada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomoya","family":"Tsukada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Kinoshita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katsunobu","family":"Oyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomoharu","family":"Miyashita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Itasu","family":"Ninomiya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tetsuo","family":"Ohta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,1,5]]},"reference":[{"key":"2991_CR1","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.3748\/wjg.v20.i7.1635","volume":"20","author":"M Orditura","year":"2014","unstructured":"Orditura M, Galizia G, Sforza V, et al. Treatment of gastric cancer. World j gastroenterol. 2014;20:1635\u201349.","journal-title":"World j gastroenterol"},{"key":"2991_CR2","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1002\/1097-0142(19890215)63:4<613::AID-CNCR2820630402>3.0.CO;2-0","volume":"63","author":"H Yamazaki","year":"1989","unstructured":"Yamazaki H, Oshima A, Murakami R, et al. A long-term follow-up study of patients with gastric cancer detected by mass screening. Cancer. 1989;63:613\u20137.","journal-title":"Cancer"},{"key":"2991_CR3","first-page":"874","volume":"49","author":"CY Chen","year":"2002","unstructured":"Chen CY, Wu CW, Lo SS, et al. Peritoneal carcinomatosis and lymph node metastasis are prognostic indicators in patients with borrmann type IV gastric carcinoma. Hepatogastroenterology. 2002;49:874\u20137.","journal-title":"Hepatogastroenterology"},{"key":"2991_CR4","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1007\/s10120-006-0370-y","volume":"9","author":"K Maruyama","year":"2006","unstructured":"Maruyama K, Kaminishi M, Hayashi K, et al. Gastric cancer treated in 1991 in Japan: data analysis of nationwide registry. Gastric cancer. 2006;9:51\u201366.","journal-title":"Gastric cancer"},{"key":"2991_CR5","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1002\/(SICI)1097-0142(20000115)88:2<358::AID-CNCR16>3.0.CO;2-O","volume":"88","author":"B Sadeghi","year":"2000","unstructured":"Sadeghi B, Arvieux C, Glehen O, et al. Peritoneal carcinomatosis from non-gynecologic malignancies: results of the EVOCAPE 1 multicentric prospective study. Cancer. 2000;88:358\u201363.","journal-title":"Cancer"},{"key":"2991_CR6","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/S1470-2045(08)70035-4","volume":"9","author":"W Koizumi","year":"2008","unstructured":"Koizumi W, Narahara H, Hara T, et al. S-1 plus cisplatin versus S-1 alone for first-line treatment of advanced gastric cancer (SPIRITS trial): a phase III trial. Lancet oncol. 2008;9:215\u201321.","journal-title":"Lancet oncol"},{"key":"2991_CR7","first-page":"1305","volume":"19","author":"S Fushida","year":"2008","unstructured":"Fushida S, Kinoshita J, Yagi Y, et al. Dual anti-cancer effects of weekly intraperitoneal docetaxel in treatment of advanced gastric cancer patients with peritoneal carcinomatosis: a feasibility and pharmacokinetic study. Oncol rep. 2008;19:1305\u201310.","journal-title":"Oncol rep"},{"key":"2991_CR8","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1093\/jjco\/hyt114","volume":"43","author":"K Shirao","year":"2013","unstructured":"Shirao K, Boku N, Yamada Y, et al. Randomized phase III study of 5-fluorouracil continuous infusion vs. Sequential methotrexate and 5-fluorouracil therapy in far advanced gastric cancer with peritoneal metastasis (JCOG0106). Jpn j clin oncol. 2013;43:972\u201380.","journal-title":"Jpn j clin oncol"},{"key":"2991_CR9","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1007\/s00280-013-2122-0","volume":"71","author":"S Fushida","year":"2013","unstructured":"Fushida S, Kinoshita J, Kaji M, et al. Phase I\/II study of intraperitoneal docetaxel plus S-1 for the gastric cancer patients with peritoneal carcinomatosis. Cancer chemother pharmacol. 2013;71:1265\u201372.","journal-title":"Cancer chemother pharmacol"},{"key":"2991_CR10","doi-asserted-by":"crossref","first-page":"6","DOI":"10.4236\/jct.2013.49A1002","volume":"4","author":"S Fushida","year":"2013","unstructured":"Fushida S, Oyama K, Kinoshita J, et al. Intraperitoneal chemotherapy as a multimodal treatment for gastric cancer patients with peritoneal metastasis. J cancer ther. 2013;4:6\u201315.","journal-title":"J cancer ther"},{"key":"2991_CR11","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.amjsurg.2004.06.010","volume":"188","author":"E Otsuji","year":"2004","unstructured":"Otsuji E, Kuriu Y, Okamoto K, et al. Outcome of surgical treatment for patients with scirrhous carcinoma of the stomach. Am j surg. 2004;188:327\u201332.","journal-title":"Am j surg"},{"key":"2991_CR12","doi-asserted-by":"crossref","first-page":"1668","DOI":"10.1002\/(SICI)1097-0142(19960415)77:8<1668::AID-CNCR37>3.0.CO;2-W","volume":"77","author":"M Yashiro","year":"1996","unstructured":"Yashiro M, Chung YS, Nishimura S, et al. Fibrosis in the peritoneum induced by scirrhous gastric cancer cells may act as \u201csoil\u201d for peritoneal dissemination. Cancer. 1996;77:1668\u201375.","journal-title":"Cancer"},{"key":"2991_CR13","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.jss.2012.10.052","volume":"182","author":"C Zhang","year":"2013","unstructured":"Zhang C, Awasthi N, Schwarz MA, et al. Establishing a peritoneal dissemination xenograft mouse model for survival outcome assessment of experimental gastric cancer. J surg res. 2013;182:227\u201334.","journal-title":"J surg res"},{"key":"2991_CR14","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1007\/BF00157685","volume":"14","author":"M Yashiro","year":"1996","unstructured":"Yashiro M, Chung YS, Nishimur S, et al. Peritoneal metastatic model for human scirrhous gastric carcinoma in nude mice. Clin exp metastasis. 1996;14:43\u201354.","journal-title":"Clin exp metastasis"},{"key":"2991_CR15","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1007\/BF02347524","volume":"30","author":"H Kotanagi","year":"1995","unstructured":"Kotanagi H, Saito Y, Shiozawa N, et al. Establishment of a human cancer cell line with high potential for peritoneal dissemination. J gastroenterol. 1995;30:437\u20138.","journal-title":"J gastroenterol"},{"key":"2991_CR16","doi-asserted-by":"crossref","first-page":"476","DOI":"10.3892\/ijo.2012.1490","volume":"41","author":"T Tsukada","year":"2012","unstructured":"Tsukada T, Fushida S, Harada S, et al. The role of human peritoneal mesothelial cells in the fibrosis and progression of gastric cancer. Int j oncol. 2012;41:476\u201382.","journal-title":"Int j oncol"},{"key":"2991_CR17","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/978-1-4613-1247-5_3","volume":"82","author":"PH Sugarbaker","year":"1996","unstructured":"Sugarbaker PH, Stuart OA, Vidal-Jove J, et al. Pharmacokinetics of the peritonealplasma barrier after systemic mitomycin C administration. Cancer treat res. 1996;82:41\u201352.","journal-title":"Cancer treat res"},{"key":"2991_CR18","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1177\/089686080602600207","volume":"26","author":"S Yung","year":"2006","unstructured":"Yung S, Li FK, Chan TM. Peritoneal mesothelial cell culture and biology. Perit dial int. 2006;26:162\u201373.","journal-title":"Perit dial int"},{"key":"2991_CR19","first-page":"795","volume":"8","author":"Y Yonemura","year":"1996","unstructured":"Yonemura Y, Endo Y, Yamaguchi T, et al. Mechanisms of the formation of the peritoneal dissemination in gastric cancer. Int j oncol. 1996;8:795\u201302.","journal-title":"Int j oncol"},{"key":"2991_CR20","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1007\/s00441-010-1029-x","volume":"342","author":"ST Buckley","year":"2010","unstructured":"Buckley ST, Medina C, Ehrhardt C. Differential susceptibility to epithelialmesenchymal transition (EMT) of alveolar, bronchial and intestinal epithelial cells in vitro and the effect of angiotensin II receptor inhibition. Cell tissue res. 2010;342:39\u201351.","journal-title":"Cell tissue res"},{"key":"2991_CR21","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1038\/cr.2009.5","volume":"19","author":"J Xu","year":"2009","unstructured":"Xu J, Lamouille S, Derynck R. TGF-beta-induced epithelial to mesenchymal transition. Cell res. 2009;19:156\u201372.","journal-title":"Cell res"},{"key":"2991_CR22","doi-asserted-by":"crossref","first-page":"1776","DOI":"10.1172\/JCI200320530","volume":"112","author":"R Kalluri","year":"2003","unstructured":"Kalluri R, Neilson EG. Epithelial-mesenchymal transition and its implications for fibrosis. J clin invest. 2003;112:1776\u201384.","journal-title":"J clin invest"},{"key":"2991_CR23","doi-asserted-by":"crossref","first-page":"553","DOI":"10.3892\/or.2014.3636","volume":"33","author":"T Shinbo","year":"2015","unstructured":"Shinbo T, Fushida S, Tsukada T, et al. Protein-bound polysaccharide K suppresses tumor fibrosis in gastric cancer by inhibiting the TGF-\u03b2 signaling pathway. Oncol rep. 2015;33:553\u20138.","journal-title":"Oncol rep"},{"key":"2991_CR24","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.canlet.2014.09.019","volume":"355","author":"M Okazaki","year":"2014","unstructured":"Okazaki M, Fushida S, Harada S, et al. The angiotensin II type 1 receptor blocker candesartan suppresses proliferation and fibrosis in gastric cancer. Cancer lett. 2014;355:46\u201353.","journal-title":"Cancer lett"},{"key":"2991_CR25","first-page":"187","volume":"27","author":"ZD Lv","year":"2011","unstructured":"Lv ZD, Na D, Ma XY, et al. Human peritoneal mesothelial cell transformation into myofibroblasts in response to TGF-\u00df1 in vitro. Int j mol med. 2011;27:187\u201393.","journal-title":"Int j mol med"},{"key":"2991_CR26","first-page":"571","volume":"1","author":"S Paget","year":"1989","unstructured":"Paget S. The distribution of secondary growths in cancer of the breast. Lancet. 1989;1:571\u20133.","journal-title":"Lancet"},{"key":"2991_CR27","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1007\/s11010-013-1583-0","volume":"377","author":"ZD Lv","year":"2013","unstructured":"Lv ZD, Wang HB, Dong Q, et al. Mesothelial cells differentiate into fibroblast-like cells under the scirrhous gastric cancer microenvironment and promote peritoneal carcinomatosis in vitro and in vivo. Mol cell biochem. 2013;377:177\u201385.","journal-title":"Mol cell biochem"},{"key":"2991_CR28","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1056\/NEJM200005043421807","volume":"342","author":"GC Blobe","year":"2000","unstructured":"Blobe GC, Schiemann WP, Lodish HF. Role of transforming growth factor beta in human disease. N engl j med. 2000;342:1350\u20138.","journal-title":"N engl j med"},{"key":"2991_CR29","doi-asserted-by":"crossref","first-page":"3056","DOI":"10.3748\/wjg.v13.i22.3056","volume":"13","author":"F Verrecchia","year":"2007","unstructured":"Verrecchia F, Mauviel A. Transforming growth factor-beta and fibrosis. World j gastroenterol. 2007;13:3056\u201362.","journal-title":"World j gastroenterol"},{"key":"2991_CR30","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1007\/s10585-010-9314-3","volume":"27","author":"Y Saito","year":"2010","unstructured":"Saito Y, Sekine W, Sano R, et al. Potentiation of cell invasion and matrix metalloproteinase production by alpha3beta1 integrin-mediated adhesion of gastric carcinoma cells to laminin-5. Clin exp metastasis. 2010;27:197\u2013205.","journal-title":"Clin exp metastasis"},{"key":"2991_CR31","doi-asserted-by":"crossref","first-page":"6065","DOI":"10.1158\/0008-5472.CAN-04-0321","volume":"64","author":"H Takatsuki","year":"2004","unstructured":"Takatsuki H, Komatsu S, Sano R, et al. Adhesion of gastric carcinoma cells to peritoneum mediated by alpha3beta1 integrin (VLA-3). Cancer res. 2004;64:6065\u201370.","journal-title":"Cancer res"},{"key":"2991_CR32","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1007\/PL00011698","volume":"3","author":"Y Yonemura","year":"2000","unstructured":"Yonemura Y, Endou Y, Fujita H, et al. Role of MMP-7 in the formation of peritoneal dissemination in gastric cancer. Gastric cancer. 2000;3:63\u201370.","journal-title":"Gastric cancer"},{"key":"2991_CR33","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1046\/j.1365-2168.2000.01358.x","volume":"87","author":"Y Maehara","year":"2000","unstructured":"Maehara Y, Hasuda S, Koga T, et al. Postoperative outcome and sites of recurrence in patients following curative resection of gastric cancer. Br j surg. 2000;87:353\u20137.","journal-title":"Br j surg"},{"key":"2991_CR34","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1007\/s00268-001-0143-z","volume":"25","author":"E Otsuji","year":"2001","unstructured":"Otsuji E, Kobayashi S, Okamoto K, et al. Is timing of death from tumor recurrence predictable after curative resection for gastric cancer? World j surg. 2001;25:1373\u20136.","journal-title":"World j surg"},{"key":"2991_CR35","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1007\/s00268-004-7359-7","volume":"28","author":"E Otsuji","year":"2004","unstructured":"Otsuji E, Kuriu Y, Ichikawa D, et al. Time to death and pattern of death in recurrence following curative resection of gastric carcinoma: analysis based on depth of invasion. World j surg. 2004;28:866\u20139.","journal-title":"World j surg"},{"key":"2991_CR36","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/S0002-9610(02)01377-6","volume":"185","author":"S Ohno","year":"2003","unstructured":"Ohno S, Fujii T, Ueda S, et al. Predictive factors and timing for liver recurrence after curative resection of gastric carcinoma. Am j surg. 2003;185:258\u201363.","journal-title":"Am j surg"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-016-2991-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,28]],"date-time":"2020-09-28T15:08:43Z","timestamp":1601305723000},"score":1,"resource":{"primary":{"URL":"http:\/\/bmccancer.biomedcentral.com\/articles\/10.1186\/s12885-016-2991-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,1,5]]},"references-count":36,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["2991"],"URL":"https:\/\/doi.org\/10.1186\/s12885-016-2991-9","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,1,5]]},"article-number":"23"}}